Copyright
©The Author(s) 2004.
World J Gastroenterol. Sep 1, 2004; 10(17): 2595-2597
Published online Sep 1, 2004. doi: 10.3748/wjg.v10.i17.2595
Published online Sep 1, 2004. doi: 10.3748/wjg.v10.i17.2595
Table 3 Immune treatment of DCs (mean ± SD, n = 10)
Group | Tumor diameter after inoculation (mm) | |||
d 7 | d 12 | d 15 | d 18 | |
Control | 5.72 ± 0.02 | 7.88 ± 0.09 | 9.20 ± 0.11 | 11.90 ± 0.09 |
DC | 4.70 ± 0.03 | 7.71 ± 0.08 | 9.02 ± 0.04 | 10.70 ± 0.68 |
Wtp53DC | 5.03 ± 0.09 | 6.90 ± 0.09 | 7.13 ± 0.11 | 8.29 ± 0.05 |
LyDC | 5.06 ± 0.01 | 6.13 ± 0.08 | 7.10 ± 0.05 | 8.77 ± 0.03 |
Lywtp53 | 5.19 ± 0.09 | 5.10 ± 0.39 | 6.73 ± 0.66a | 6.79 ± 0.77a |
-
Citation: Sun HW, Tang QB, Cheng YJ, Zou SQ. Effects of dendritic cells transfected with full-length wild-type
p53 and stimulated by gastric cancer lysates on immune response. World J Gastroenterol 2004; 10(17): 2595-2597 - URL: https://www.wjgnet.com/1007-9327/full/v10/i17/2595.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i17.2595